M3 (4YC) Price & Analysis

0 Followers

4YC Stock Chart & Stats

€11.70

€0.25(2.92%)

At close: Jan 08 4:00 PM EST

€11.70

€0.25(2.92%)

Day’s Range― - ―

52-Week Range€7.04 - €15.10

Previous CloseN/A

Volume114.00

Average Volume (3M)5.00

Market Cap

€7.04B

Enterprise Value€951.20B

Total Cash (Recent Filing)€156.18B

Total Debt (Recent Filing)€33.15B

Price to Earnings (P/E)25.9

Beta1.14

Next Earnings

Aug 06, 2026

EPS Estimate

0.11

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)72.52

Shares Outstanding679,124,300

10 Day Avg. Volume10

30 Day Avg. Volume5

Financial Highlights & Ratios

PEG Ratio1.02

Price to Book (P/B)2.66

Price to Sales (P/S)3.09

P/FCF Ratio17.37

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€11.74

Price Target Upside0.37% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering8

EPS Forecast (FY)0.44

Revenue Forecast (FY)€2.14B

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetVery low leverage (debt-to-equity ~0.08) provides durable financial flexibility. This helps the company fund product development, absorb industry cyclicality, and pursue opportunistic M&A or buybacks without stressing liquidity, supporting stability over months.

Strong Free Cash FlowHigh free cash flow relative to earnings (≈0.89x) indicates strong cash generation and earnings quality. Persistently healthy FCF supports reinvestment in platform capabilities, dividends, or strategic acquisitions and reduces reliance on external financing over the medium term.

Re-accelerating Revenue & Healthy MarginsRe-accelerating top-line growth with robust gross and net margins reflects durable demand for healthcare digital services and an efficient platform model. These trends support sustainable profitability and cash generation as the company scales its clinician and enterprise offerings.

Bears Say

Margin CompressionProfitability has declined from prior peaks, suggesting cost pressures or a less favorable revenue mix. If these factors are structural rather than temporary, sustained margin compression would reduce free cash flow and constrain reinvestment or shareholder returns over the coming months.

Inconsistent Cash ConversionOperating cash conversion varies materially year-to-year, implying working-capital timing or collection issues. This inconsistency can create volatility in available cash for capital allocation, limiting predictable funding for growth initiatives, dividends, or M&A in the medium term.

Declining Return On EquityROE has fallen from earlier peaks, indicating reduced capital efficiency. If the trend persists it may reflect competitive pressures or slower monetization of network assets, which can lower long-term shareholder returns and weaken the leverage of new investments.

M3 News

M3 Leaves Share Buyback Authorization Untapped Through June 2026

An update from M3 ( ($JP:2413) ) is now available. M3, Inc. reported that during the period from...

10d ago

M3 Affirms Independence Despite Sony’s 34.5% Stake and Reports No Dealings in FY2025

M3 ( ($JP:2413) ) just unveiled an announcement. M3, Inc., a Tokyo-based digital healthcare and medical information services...

29d ago

M3 to Consolidate WISEMAN Through Share Acquisition

The latest update is out from M3 ( ($JP:2413) ). M3, Inc. has announced the acquisition of shares...

1M ago

M3 to Acquire WISEMAN to Boost Healthcare and Nursing Care DX

M3 ( ($JP:2413) ) just unveiled an update. M3, Inc. has decided to acquire all outstanding shares of...

1M ago

M3 Reports No Share Buybacks So Far Under ¥20 Billion Repurchase Plan

M3 ( ($JP:2413) ) has provided an announcement. M3, Inc. reported that it did not repurchase any of...

1M ago

M3 Issues Investor Presentation With Caution on Projections

M3 ( ($JP:2413) ) just unveiled an announcement. M3, Inc. has released a presentation outlining forecasts, plans, management...

2M ago

M3 Launches Up to ¥20 Billion Share Buyback to Bolster Capital Efficiency

M3 ( ($JP:2413) ) has shared an update. M3, Inc. has approved a share repurchase program of up...

2M ago

M3 Lifts Profit 21% and Hikes Dividend as It Targets Further Growth in FY2027

M3 ( ($JP:2413) ) has provided an update. M3 reported strong results for the fiscal year ended March...

2M ago

Is MTHRF a Buy, Before Earnings?

M3 (MTHRF) is scheduled to report 4th quarter earnings on 05/01/2026, before the market opens. Regarding Q4 estimates,...

2M ago

M3 Completes ¥20 Billion Share Buyback, Tightening Free Float

The latest update is out from M3 ( ($JP:2413) ). M3, Inc. has completed a share repurchase program...

4M ago

M3 Inc. downgraded to Neutral from Buy at Goldman Sachs

Goldman Sachs downgraded M3 Inc. (MTHRF) to Neutral from Buy with a 2,500 yen price target The firm...

9M ago

M3 Inc. initiated with a Buy at Goldman Sachs

Goldman Sachs analyst Akinori Ueda initiated coverage of M3 Inc. with a Buy rating and 5,450 yen price...

4y ago

MTHRF

4YC FAQ

What was M3 Inc’s price range in the past 12 months?

M3 Inc lowest stock price was €7.04 and its highest was €15.10 in the past 12 months.

What is M3 Inc’s market cap?

M3 Inc’s market cap is €7.04B.

When is M3 Inc’s upcoming earnings report date?

M3 Inc’s upcoming earnings report date is Aug 06, 2026 which is in 26 days.

How were M3 Inc’s earnings last quarter?

M3 Inc released its earnings results on May 01, 2026. The company reported €0.06 earnings per share for the quarter, missing the consensus estimate of €0.076 by -€0.016.

Is M3 Inc overvalued?

According to Wall Street analysts M3 Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does M3 Inc pay dividends?

M3 Inc does not currently pay dividends.

What is M3 Inc’s EPS estimate?

M3 Inc’s EPS estimate is 0.11.

How many shares outstanding does M3 Inc have?

M3 Inc has 679,124,300 shares outstanding.

What happened to M3 Inc’s price movement after its last earnings report?

M3 Inc reported an EPS of €0.06 in its last earnings report, missing expectations of €0.076. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of M3 Inc?

Currently, no hedge funds are holding shares in DE:4YC

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

M3 Inc

M3, Inc. is a Japanese company that delivers a broad spectrum of internet-based services, predominantly catering to medical professionals and the broader healthcare industry. Its operations are segmented into five key areas: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. M3 manages several specialized online platforms, including m3.com, an exclusive information portal for healthcare professionals; MR-kun, which ensures member doctors receive ongoing updates via the m3com platform; QOL-kun, offering non-medical life support; and AskDoctors, where certified physicians address public health inquiries from the general public. Internationally, it operates MDLinx for U.S. medical professionals and Doctorsnetuk, a U.K.-based site supporting pharmaceutical companies and providing drug information databases across France, Germany, and Spain. Furthermore, M3 offers dedicated career services for doctors and pharmacists through its m3com CAREER platform. Its diverse business portfolio extends to sales and marketing for pharmaceutical and medical device companies, as well as the development, sale, and maintenance of electronic medical records and equipment for healthcare facilities. M3 also conducts surveys for medical professionals, offers online sales and marketing assistance to pharmaceutical firms, provides management consulting to medical institutions, delivers home-visit nursing services, and specializes in human resource solutions for healthcare staff, alongside managing clinical trial facilities. Established in 2000, the company was initially named So-netM3, Inc., before rebranding to M3, Inc. in January 2010. Its headquarters are located in Tokyo, Japan.

M3 (4YC) Earnings & Revenues

Historic Earnings Reports

4YC Stock 12 Month Forecast

Average Price Target

€11.74

▲(0.37% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"7":"€7","18":"€18","9.75":"€9.75","12.5":"€12.5","15.25":"€15.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":17.7771,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€17.78</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11.74366,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€11.74</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8.6192,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€8.62</span>\n  </div></div>","useHTML":true}}],"tickPositions":[7,9.75,12.5,15.25,18],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.386,10.03146923076923,10.67693846153846,11.322407692307692,11.967876923076922,12.613346153846154,13.258815384615385,13.904284615384615,14.549753846153846,15.195223076923078,15.840692307692308,16.486161538461538,17.13163076923077,{"y":17.7771,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.386,9.567358461538461,9.748716923076923,9.930075384615384,10.111433846153846,10.292792307692308,10.47415076923077,10.65550923076923,10.836867692307692,11.018226153846154,11.199584615384616,11.380943076923076,11.562301538461538,{"y":11.74366,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.386,9.327015384615384,9.26803076923077,9.209046153846153,9.150061538461538,9.091076923076923,9.032092307692308,8.973107692307691,8.914123076923076,8.855138461538461,8.796153846153846,8.73716923076923,8.678184615384614,{"y":8.6192,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":11.04,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.547,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.716,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.814,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.73,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.307,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.237,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.35,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.822,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.138,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.386,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >